Camorani S - Search Results

1

Aptamer targeting EGFRvIII mutant hampers its constitutive autophosphorylation and affects migration, invasion and proliferation of glioblastoma cells.

Camorani S, Crescenzi E, Colecchia D, Carpentieri A, Amoresano A, Fedele M, Chiariello M, Cerchia L. Camorani S, et al. Oncotarget. 2015 Nov 10;6(35):37570-87. doi: 10.18632/oncotarget.6066. Oncotarget. 2015. PMID: 26461476 Free PMC article.

2

Targeting Axl with an high-affinity inhibitory aptamer.

Cerchia L, Esposito CL, Camorani S, Rienzo A, Stasio L, Insabato L, Affuso A, de Franciscis V. Cerchia L, et al. Among authors: camorani s. Mol Ther. 2012 Dec;20(12):2291-303. doi: 10.1038/mt.2012.163. Epub 2012 Aug 21. Mol Ther. 2012. PMID: 22910292 Free PMC article.

3

Inhibition of receptor signaling and of glioblastoma-derived tumor growth by a novel PDGFRβ aptamer.

Camorani S, Esposito CL, Rienzo A, Catuogno S, Iaboni M, Condorelli G, de Franciscis V, Cerchia L. Camorani S, et al. Mol Ther. 2014 Apr;22(4):828-41. doi: 10.1038/mt.2013.300. Epub 2014 Jan 2. Mol Ther. 2014. PMID: 24566984 Free PMC article.

4

Oligonucleotide aptamers for glioma targeting: an update.

Camorani S, Cerchia L. Camorani S, et al. Cent Nerv Syst Agents Med Chem. 2015;15(2):126-37. doi: 10.2174/1871524915666150430122525. Cent Nerv Syst Agents Med Chem. 2015. PMID: 25924917

5

Coupling Aptamers to Short Interfering RNAs as Therapeutics.

Cerchia L, Esposito CL, Camorani S, Catuogno S, Franciscis V. Cerchia L, et al. Among authors: camorani s. Pharmaceuticals (Basel). 2011 Oct 27;4(11):1434-1449. doi: 10.3390/ph4111434. Pharmaceuticals (Basel). 2011. PMID: 27721331 Free PMC article. Review.

6

Aptamer-mediated impairment of EGFR-integrin αvβ3 complex inhibits vasculogenic mimicry and growth of triple-negative breast cancers.

Camorani S, Crescenzi E, Gramanzini M, Fedele M, Zannetti A, Cerchia L. Camorani S, et al. Sci Rep. 2017 Apr 20;7:46659. doi: 10.1038/srep46659. Sci Rep. 2017. PMID: 28425453 Free PMC article.

7

Aptamer Functionalization of Nanosystems for Glioblastoma Targeting through the Blood-Brain Barrier.

Monaco I, Camorani S, Colecchia D, Locatelli E, Calandro P, Oudin A, Niclou S, Arra C, Chiariello M, Cerchia L, Comes Franchini M. Monaco I, et al. Among authors: camorani s. J Med Chem. 2017 May 25;60(10):4510-4516. doi: 10.1021/acs.jmedchem.7b00527. Epub 2017 May 10. J Med Chem. 2017. PMID: 28471660

8

Inhibition of Bone Marrow-Derived Mesenchymal Stem Cells Homing Towards Triple-Negative Breast Cancer Microenvironment Using an Anti-PDGFRβ Aptamer.

Camorani S, Hill BS, Fontanella R, Greco A, Gramanzini M, Auletta L, Gargiulo S, Albanese S, Lucarelli E, Cerchia L, Zannetti A. Camorani S, et al. Theranostics. 2017 Aug 22;7(14):3595-3607. doi: 10.7150/thno.18974. eCollection 2017. Theranostics. 2017. PMID: 28912898 Free PMC article.

9

PATZ1 is a new prognostic marker of glioblastoma associated with the stem-like phenotype and enriched in the proneural subtype.

Guadagno E, Vitiello M, Francesca P, Calì G, Caponnetto F, Cesselli D, Camorani S, Borrelli G, Califano M, Cappabianca P, Arra C, Crescenzi E, Cerchia L, De Caro MLDB, Fedele M. Guadagno E, et al. Among authors: camorani s. Oncotarget. 2017 Jul 25;8(35):59282-59300. doi: 10.18632/oncotarget.19546. eCollection 2017 Aug 29. Oncotarget. 2017. PMID: 28938636 Free PMC article.

10

Oligonucleotide aptamers against tyrosine kinase receptors: Prospect for anticancer applications.

Camorani S, Crescenzi E, Fedele M, Cerchia L. Camorani S, et al. Biochim Biophys Acta Rev Cancer. 2018 Apr;1869(2):263-277. doi: 10.1016/j.bbcan.2018.03.003. Epub 2018 Mar 21. Biochim Biophys Acta Rev Cancer. 2018. PMID: 29574128 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters